Key Highlights
- Moderna (NASDAQ:MRNA) will join the Nasdaq-100 before the market opens on October 9, 2026, replacing Warner Bros. Discovery (NASDAQ:WBD), Nasdaq said after the close on October 1.
- Moderna (NASDAQ:MRNA) has risen 541 percent this year, making it the S&P 500's second-best performer, and its value is roughly USD 75 billion.
- Shares rose about 2.4 percent premarket on October 2, adding to a gain of about 563 percent over the past twelve months.
- Warner Bros. Discovery is leaving major indexes because its Merger with a larger media company is expected to close on October 6.
How the Swap Works
Nasdaq announced that Moderna will replace Warner Bros. Discovery in the Nasdaq-100 effective before the open on October 9, 2026. The change is mechanical: Warner Bros. Discovery is leaving because it is being acquired, creating a vacancy. Funds that track the Nasdaq-100 must buy Moderna and sell the departing stock around the effective date, which can create concentrated demand. index providers also remove stocks that are being acquired, so Warner Bros. Discovery's exit is a direct result of the merger. Nasdaq-100 index funds, including the Invesco QQQ Trust (NASDAQ:QQQ), hold stocks in proportion to index weights.
The Rally Behind the Inclusion
Moderna's shares have jumped more than sixfold this year to a value of roughly USD 75 billion, a swing that put it among the best performers in the S&P 500. The move has also drawn retail attention to other biotech stocks, with traders comparing smaller names to Moderna's rally. Inclusion is a sign of size and liquidity, not an endorsement of fundamentals. The material reviewed does not detail what drove the rally, so investors should check recent company filings and trial results.
Risks Around Index Inclusion
Stocks often rise between announcement and effective date because of anticipated buying, and then can give back gains afterward. Moderna (NASDAQ:MRNA) has a very large year-to-date gain, so its price is sensitive to any disappointment. A rally of 541 percent in nine months also means expectations are high. Index Funds must buy regardless of valuation, so the Demand is not based on views about future earnings. Investors should watch for the effective date, trading Volume around the open on October 9 and any pullback after. Investors who buy only because of index inclusion take on the risk that demand fades once the effective date passes.
Where Things Stand
Moderna (NASDAQ:MRNA) is joining the Nasdaq-100 because Warner Bros. Discovery is leaving as part of a merger, and Moderna's Market Value qualified after a 541 percent rally. Inclusion can attract index buying but does not change the underlying business. The Invesco QQQ Trust (NASDAQ:QQQ) and other tracking funds will adjust holdings by the effective date. Investors should separate the mechanical flows from fundamentals. The inclusion itself is confirmed, but the stock's future path is not.





_11_20_2026_12_38_15_908731.jpg)
Please wait processing your request...